These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 34835109)
1. The Progestin Medroxyprogesterone Acetate Affects HIV-1 Production in Human Lymphoid Tissue Explants in a Dose-Dependent and Glucocorticoid-like Fashion. Vanpouille C; Günaydın G; Jangard M; Clerici M; Margolis L; Broliden K; Introini A Viruses; 2021 Nov; 13(11):. PubMed ID: 34835109 [TBL] [Abstract][Full Text] [Related]
2. The contraceptive medroxyprogesterone acetate, unlike norethisterone, directly increases R5 HIV-1 infection in human cervical explant tissue at physiologically relevant concentrations. Ray RM; Maritz MF; Avenant C; Tomasicchio M; Dlamini S; van der Spuy Z; Hapgood JP Sci Rep; 2019 Mar; 9(1):4334. PubMed ID: 30867477 [TBL] [Abstract][Full Text] [Related]
3. Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanisms. Huijbregts RP; Helton ES; Michel KG; Sabbaj S; Richter HE; Goepfert PA; Hel Z Endocrinology; 2013 Mar; 154(3):1282-95. PubMed ID: 23354099 [TBL] [Abstract][Full Text] [Related]
4. The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor. Tomasicchio M; Avenant C; Du Toit A; Ray RM; Hapgood JP PLoS One; 2013; 8(5):e62895. PubMed ID: 23658782 [TBL] [Abstract][Full Text] [Related]
5. The injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptor. Govender Y; Avenant C; Verhoog NJ; Ray RM; Grantham NJ; Africander D; Hapgood JP PLoS One; 2014; 9(5):e96497. PubMed ID: 24840644 [TBL] [Abstract][Full Text] [Related]
6. Medroxyprogesterone acetate, unlike norethisterone, increases HIV-1 replication in human peripheral blood mononuclear cells and an indicator cell line, via mechanisms involving the glucocorticoid receptor, increased CD4/CD8 ratios and CCR5 levels. Maritz MF; Ray RM; Bick AJ; Tomasicchio M; Woodland JG; Govender Y; Avenant C; Hapgood JP PLoS One; 2018; 13(4):e0196043. PubMed ID: 29698514 [TBL] [Abstract][Full Text] [Related]
7. Increased HIV-1 infection in PBMCs treated in vitro with menstrual cycle phase hormones or medroxyprogesterone acetate likely occurs via different mechanisms. Bick AJ; Avenant C; Tomasicchio M; van der Spuy Z; Hapgood JP Am J Reprod Immunol; 2022 Dec; 88(6):e13643. PubMed ID: 36302121 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women. Heffron R; Achilles SL; Dorflinger LJ; Hapgood JP; Kiarie J; Polis CB; Steyn PS Contraception; 2019 Apr; 99(4):199-204. PubMed ID: 30576636 [TBL] [Abstract][Full Text] [Related]
9. Exploring the immunomodulatory role of depot medroxyprogesterones acetate and endogenous progesterone levels in HIV infected and uninfected women. Mnqonywa N; Abbai N; Ragupathy V; Ramjee G; Hewlett I; Moodley D BMC Res Notes; 2019 Nov; 12(1):745. PubMed ID: 31730016 [TBL] [Abstract][Full Text] [Related]
10. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot. Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869 [TBL] [Abstract][Full Text] [Related]